Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis.
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureEmpirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis.Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment.β2-Adrenergic Receptor Activation Suppresses the Rat Phenethylamine Hallucinogen-Induced Head Twitch Response: Hallucinogen-Induced Excitatory Post-synaptic Potentials as a Potential Substrate.
P2860
Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@ast
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@en
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@nl
type
label
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@ast
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@en
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@nl
prefLabel
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@ast
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@en
Azapirone 5-HT1A receptor part ...... atic review and meta-analysis.
@nl
P2093
P2860
P1476
Azapirone 5-HT1A receptor part ...... matic review and meta-analysis
@en
P2093
P2860
P304
P356
10.1017/S0033291713002857
P407
P50
P577
2013-11-21T00:00:00Z